Telaprevir in treatment of chronic hepatitis C: safety issues
The aim of review. To analyze results of controlled clinical studies of efficacy and safety of telaprevir within triple antiviral therapy of chronic hepatitis C (CHC) with evaluation of frequency and spectrum of adverse effects (AE), and also approaches of their management.Original positions. Invest...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
Gastro LLC
2012-07-01
|
| Edice: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Témata: | |
| On-line přístup: | https://www.gastro-j.ru/jour/article/view/1310 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|